Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
about
GABAergic mechanisms in the pathogenesis and treatment of epilepsyGAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.Cerebrospinal fluid zinc concentrations in febrile convulsionsSome ethical problems in Huntington's choreaGABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Acamprosate modulates experimental autoimmune encephalomyelitis.The current state of research with peripheral tissues in Huntington disease.Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.Gamma-aminobutyric acid concentration in lumbar cerebrospinal fluid from patients with febrile convulsions and controls.Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier.Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine.[Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type]Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet.Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA.Changes in cerebrospinal fluid associated with dementia.Combined effect between two functional polymorphisms of SLC6A12 gene is associated with temporal lobe epilepsy.Pharmacologic Treatment of TremorExcitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy
P2860
Q28271123-9FB82D78-77EA-4BBA-ABE8-D23A2FEBE3E5Q34094997-936543D4-32BC-44F1-825B-0D9868A8DB82Q34313340-95E0B884-5C07-4B8C-A9B0-64E525330636Q34797169-C674DFD3-295F-4EF0-9F79-273EAE4DAF4FQ35776409-A7811003-6DEC-42CC-834B-35A63C1F99C3Q35884948-79405138-F9EC-4C56-A545-1919ACD168A7Q37019894-B26769D1-316A-4035-89FD-3AF058E13F85Q37026486-A14EF284-8B85-4917-BEA2-7C2254E9AEAAQ38271572-039315C6-850C-4874-A255-B8217CF45116Q38639337-9C7A8D56-266F-4FA9-A653-63A8A75F45F1Q39686256-01F34B28-D5BE-4498-8553-E1DD40D489C8Q40141698-CE04D21F-28BA-4CA3-B4F1-BBA777827383Q40320448-D24DDE82-3B19-4635-8CD8-0EFCE76388EBQ40756775-F0C52488-3C7D-48C6-8883-3D9F7E7D0BDEQ40775502-98CF5743-E0CB-4F26-B9A2-EB64C6009DECQ41546721-77520255-2A6B-41CF-8C9D-B5781E123104Q41574564-F500D470-76E3-4B26-A62D-16E1FDD59FAEQ42243705-24DC2323-038C-4A5E-A28E-34B65545FDB8Q42555129-3B22D5AB-AF92-4C8D-B746-CD46944D8B4CQ42555682-238266DF-D015-4B4E-A4E4-C5DF58A9F836Q45012786-43CD1EB8-2D25-47BE-85DA-670FAA59E86CQ45299155-AD6F3C12-4E01-451A-9476-9B60ED7501F8Q45306804-C7FDBF63-0228-41FC-9F63-10676CEEB774Q47937645-03F2ABF8-7F60-4C47-8854-DA0BE41572C8Q48866249-9DDE30F5-A187-467C-847C-5F2781E86186Q50000197-381844E1-832B-479E-A86A-FB3E2D41CF99Q52097336-4244BA88-5487-42DA-9B69-08B3B118F4D7Q53195206-2721C14C-F848-48FE-A27A-72C64CAAAF9DQ53241543-36DE8B2C-182B-4D6C-A643-A742CEB24217Q56227762-171AF949-5599-42C0-89D7-F9427C801974Q57982902-1C39E9AC-4B03-49AF-99D3-163CC853F843
P2860
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@en
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@nl
type
label
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@en
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@nl
altLabel
Levels of -Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
@en
prefLabel
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@en
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@nl
P2093
P1433
P1476
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1980.00500550054006
P577
1980-06-01T00:00:00Z